Key points are not available for this paper at this time.
The mobilization failure was associated with limited survival. Nonetheless, collected products offered perspectives for ex vivo expansion. Further studies should investigate the feasibility of expanding collected CD34+ cells to use as grafts for ASCT.
Bourdıeu et al. (Sat,) studied this question.